Abstract Various studies performed in cultured cells and in in vivo models of neuronal damage showed that cannabinoids exert a…
Abstract Current pharmacotherapy of Parkinson’s disease (PD) is palliative and unable to modify the progression of neurodegeneration. Treatments that can…
Abstract Background: Cannabidiol (CBD) is a natural component of cannabis that possesses a widespread and complex immunomodulatory, antioxidant, anxiolytic, and…
Abstract Stroke is an important cause of morbidity and mortality worldwide. Development of novel neuroprotectants is of paramount importance. This…
Abstract N-arachidonoyl glycine (NAGly) is an endocannabinoid involved in the regulation of different immune cells. It was shown to activate…
Abstract Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the…
Abstract Background: Emerging neuroprotective strategies are being explored to preserve the retina from degeneration, that occurs in eye pathologies like…
Abstract Objective: Cannabinoid-based medications provide not only relief for specific symptoms, but also arrest or delay of disease progression in…
Abstract Several cannabinoids afforded neuroprotection in experimental models of Huntington’s disease (HD). We investigated whether a 1:1 combination of botanical…
Abstract The present study reports the behavioral, electrophysiological, and neuropathological effects of cannabidiol (CBD), a major non-psychotropic constituent of Cannabis…